Go to homepage
Privacy Policy Cookie Policy Terms of sales Impressum Shipping costs Distributors
Log in or Sign up
Go to homepage
LEARN
  • OUR TECHNOLOGIES
    • RiboLace
    • LaceSeq
    • AHARIBO
    • nano-tRNAseq
    • Martian
    • ReCet
    • DOORs
  • APPLICATIONS
    • Disease Mechanisms
    • Drug Discovery and Repurposing
    • Drug treatments and Diagnostics
    • Neo-antigens and alternative proteoforms
    • Ribosome Heterogeneity and Specialization
PRODUCTS
  • Ribosome profiling
    • Ribosome purification
    • Library preparation
    • Full workflow
  • tRNA Sequencing
  • In vitro translation
  • Proteomics
  • Transcriptome profiling
SERVICES
  • Ribosome Profiling
    • Active
    • Standard
  • tRNA sequencing
    • nano-tRNAseq
    • Ribo-tRNAseq
  • Polysome Profiling
  • Translatome biomarker discovery
  • Bioinformatic services
  • In vitro translation
RESOURCES
  • Blog
  • Publications
  • Webinar & Podcast
  • Application notes
  • White paper and eBook
  • All Resources
COMPANY
  • ABOUT IMMAGINA
  • NEWS
  • CAREERS
  • EVENTS
CONTACT
Your account
Log in
or sign up
Overview Your profile Addresses Payment methods Orders Offers
€0.00*
Privacy Policy Cookie Policy Terms of sales Impressum Shipping costs Distributors
Show all categories In vitro translation
Back Show In vitro translation
  1. Home
  2. PRODUCTS
  3. In vitro translation
Category
  • Ribosome profiling
  • tRNA Sequencing
  • In vitro translation
  • Proteomics
  • Transcriptome profiling
Applications
  • Ribosomal profiling
  • Translatome analysis
  • Lysis
  • Phospho RNA
  • tRNA-seq

ReCet - HEK293

ReCet™ is a reconstituted cell-free translation system designed to simplify the study of complex translation dynamics.

By separating and reconstituting the core components of protein synthesis—purified ribosomes, ribosome-depleted cytoplasmic extract, and an exogenous reporter mRNA—ReCet enables researchers to investigate the contribution of individual translation players in a controlled setting.

The system offers unmatched flexibility: mix and match ribosomes, mRNA, and cytoplasmic extracts from different sources, and let translation do the rest. Protein synthesis can be detected within one hour using luminescence (for luciferase-encoding mRNA) or Western blot, providing rapid and quantitative insights into translational efficiency.

Inspired by the Arendrup et al. (1) protocol, ReCet turns a cutting-edge technique into a plug-and-play solution — standardized, shelf-stable, and ready to ship.

What sets this apart from other commercially available methods?


ReCet (Immagina) Other commercial human IVT
What it is Reconstituted system: purified ribosomes + extract + mRNA, mixed separately All-in-one HeLa lysate, coupled transcription-translation
Flexibility Mix & match ribosomes/extracts/mRNA from different sources Fixed, one-source system
Cell source HEK293T or K562 (your choice). Or ask for your custom cell line HeLa only
Speed Results in ~1 hour Overnight 1-5 hours
Input Add mRNA directly Requires cloning into a specific vector first
Backed by Published Nature Protocols method (Arendrup et al. 2025) Proprietary - Undisclosed


1. Arendrup, F. S., Andersen, K. L., & Lund, A. H. (2025). A tripartite cell-free translation system to study mammalian translation. Nature Protocols.

Datasheet

ReCet™ is a reconstituted cell-free translation system designed to simplify the study of complex translation dynamics.

By separating and reconstituting the core components of protein synthesis—purified ribosomes, ribosome-depleted cytoplasmic extract, and an exogenous reporter mRNA—ReCet enables researchers to investigate the contribution of individual translation players in a controlled setting.

The system offers unmatched flexibility: mix and match ribosomes, mRNA, and cytoplasmic extracts from different sources, and let translation do the rest. Protein synthesis can be detected within one hour using luminescence (for luciferase-encoding mRNA) or Western blot, providing rapid and quantitative insights into translational efficiency.

Inspired by the Arendrup et al. (1) protocol, ReCet turns a cutting-edge technique into a plug-and-play solution — standardized, shelf-stable, and ready to ship.

What sets this apart from other commercially available methods?


ReCet (Immagina) Other commercial human IVT
What it is Reconstituted system: purified ribosomes + extract + mRNA, mixed separately All-in-one HeLa lysate, coupled transcription-translation
Flexibility Mix & match ribosomes/extracts/mRNA from different sources Fixed, one-source system
Cell source HEK293T or K562 (your choice). Or ask for your custom cell line HeLa only
Speed Results in ~1 hour Overnight 1-5 hours
Input Add mRNA directly Requires cloning into a specific vector first
Backed by Published Nature Protocols method (Arendrup et al. 2025) Proprietary - Undisclosed


1. Arendrup, F. S., Andersen, K. L., & Lund, A. H. (2025). A tripartite cell-free translation system to study mammalian translation. Nature Protocols.

Datasheet

A cell-free translation system obtained from Human Embryonic Kidney (HEK) 293T cells

ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
ReCet - HEK293
Shipping information

Please note that ReCet™ kit will be shipped in dry ice. Shipping is usually scheduled within 1 week of your order. 

Documentation & research papers
Protocol
Immagina Biotechnology
Subscribe to the free newsletter and do not miss any news or promotions.
Privacy *
OPERATIVE HEADQUARTERS

Immagina Biotechnology S.r.l
Viale dell'Industria 47,
38057 Pergine Valsugana (TN), Italy

SALES SUPPORT

Quoting, ordering and order status update

orders@immaginabiotech.com

PayPal PayPal Mastercard PayPal
TECHNICAL SERVICE

Technical enquiries and quality compliants

techsupport@immaginabiotech.com

IsoCertification
© 2026 Immagina Biotechnology Srl
  • Privacy Policy
  • •
  • Cookie Policy
  • •
  • Terms of sales
  • •
  • Impressum
  • •
  • Shipping costs
  • •
  • Distributors
This website uses cookies to ensure the best experience possible. More information...